
AtaiBeckley shares surged on a Bloomberg report that Eli Lilly is in talks to acquire the company, with investors waiting for deal terms. While no price or structure was disclosed, the acquisition prospect is driving a strong positive reaction versus an otherwise uncertain outcome.
AtaiBeckley shares surged on a Bloomberg report that Eli Lilly is in talks to acquire the company, with investors waiting for deal terms. While no price or structure was disclosed, the acquisition prospect is driving a strong positive reaction versus an otherwise uncertain outcome.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
strongly positive
Sentiment Score
0.55